Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4770822

COc1cccc(C(=O)Nc2ccc3c(c2)CCN(C2CCC2)CC3)c1.O=C(O)C(F)(F)F

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.53
NPC1 O15118 5/20 0.53
MAPT P10636 4/20 0.50
LMNA P02545 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
QSOX1 O00391 1/20 0.50
ALDH1A1 P00352 1/20 0.50
PKM P14618 1/20 0.50
GAA P10253 1/20 0.48
KCNK3 O14649 1/20 0.48
KCNK9 Q9NPC2 1/20 0.48
MAPK14 Q16539 1/20 0.48
KDM2B Q8NHM5 1/20 0.48
CASP3 P42574 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
HRH3 Q9Y5N1 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
TP53 P04637 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4773028 0.94 RAB9A (0.60) RAB9ANPC1MAPTLMNASMN1; SMN2
Trifluoroacetic Acid SCHEMBL4770267 0.91 HRH3 (0.57) RAB9ANPC1SMN1; SMN2PKMGAA
Trifluoroacetic Acid SCHEMBL4767622 0.90 HRH3 (0.51) RAB9ANPC1KDM2BHRH3
Trifluoroacetic Acid SCHEMBL4767946 0.90 HRH3 (0.56) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
Trifluoroacetic Acid SCHEMBL4775421 0.86 KCNK3 (0.51) RAB9ANPC1MAPTLMNASMN1; SMN2
Trifluoroacetic Acid SCHEMBL4765533 0.85 HRH3 (0.61) RAB9ANPC1SMN1; SMN2GAAHRH3
SCHEMBL4770633 0.85 HRH3 (0.64) RAB9ANPC1SMN1; SMN2PKMGAA
Trifluoroacetic Acid SCHEMBL4767916 0.84 TMPRSS2 (0.55) RAB9ANPC1MAPTSMN1; SMN2GAA
Trifluoroacetic Acid SCHEMBL4771953 0.84 MAPT (0.49) RAB9ANPC1MAPTLMNASMN1; SMN2
Trifluoroacetic Acid SCHEMBL4768399 0.84 MAPT (0.49) RAB9ANPC1MAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP claimed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US claimed
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 RAB9A 2307/4885NPC1 2009/4885MAPT 405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.